These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34331695)

  • 1. The Clinical Use of Curcumin for the Treatment of Rheumatoid Arthritis: A Systematic Review of Clinical Trials.
    Bagherniya M; Darand M; Askari G; Guest PC; Sathyapalan T; Sahebkar A
    Adv Exp Med Biol; 2021; 1291():251-263. PubMed ID: 34331695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study.
    Amalraj A; Varma K; Jacob J; Divya C; Kunnumakkara AB; Stohs SJ; Gopi S
    J Med Food; 2017 Oct; 20(10):1022-1030. PubMed ID: 28850308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of curcumin on rheumatoid arthritis: a systematic review and meta-analysis.
    Kou H; Huang L; Jin M; He Q; Zhang R; Ma J
    Front Immunol; 2023; 14():1121655. PubMed ID: 37325651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of curcumin supplementation on inflammatory biomarkers in patients with Rheumatoid Arthritis and Ulcerative colitis: A systematic review and meta-analysis.
    Ebrahimzadeh A; Abbasi F; Ebrahimzadeh A; Jibril AT; Milajerdi A
    Complement Ther Med; 2021 Sep; 61():102773. PubMed ID: 34478838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of curcumin nanomicelle on the clinical symptoms of patients with rheumatoid arthritis: A randomized, double-blind, controlled trial.
    Javadi M; Khadem Haghighian H; Goodarzy S; Abbasi M; Nassiri-Asl M
    Int J Rheum Dis; 2019 Oct; 22(10):1857-1862. PubMed ID: 31482684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
    Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
    Front Immunol; 2018; 9():2388. PubMed ID: 30420853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis.
    Chandran B; Goel A
    Phytother Res; 2012 Nov; 26(11):1719-25. PubMed ID: 22407780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin and rheumatoid arthritis: A systematic review of literature.
    Pourhabibi-Zarandi F; Shojaei-Zarghani S; Rafraf M
    Int J Clin Pract; 2021 Oct; 75(10):e14280. PubMed ID: 33914984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in Rheumatoid Arthritis, what is new?
    Gavrilă BI; Ciofu C; Stoica V
    J Med Life; 2016; 9(2):144-8. PubMed ID: 27453744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of curcumin supplementation on serum total antioxidant capacity, malondialdehyde, and disease activity in women with rheumatoid arthritis: A randomized, double-blind, placebo-controlled clinical trial.
    Pourhabibi-Zarandi F; Rafraf M; Zayeni H; Asghari-Jafarabadi M; Ebrahimi AA
    Phytother Res; 2024 Jul; 38(7):3552-3563. PubMed ID: 38699839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
    Ban A; Inaba M; Furumitsu Y; Okamoto K; Yukioka K; Goto H; Nishizawa Y
    Biomed Pharmacother; 2010 Feb; 64(2):107-12. PubMed ID: 19944558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total glucosides of paeony for rheumatoid arthritis: A systematic review of randomized controlled trials.
    Luo J; Jin DE; Yang GY; Zhang YZ; Wang JM; Kong WP; Tao QW
    Complement Ther Med; 2017 Oct; 34():46-56. PubMed ID: 28917375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
    Ruiz Garcia V; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Bernal JA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007649. PubMed ID: 28884785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
    van Herwaarden N; den Broeder AA; Jacobs W; van der Maas A; Bijlsma JW; van Vollenhoven RF; van den Bemt BJ
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010455. PubMed ID: 25264908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma level of neopterin as a marker of disease activity in treated rheumatoid arthritis patients: association with gender, disease activity and anti-CCP antibody.
    Arshadi D; Nikbin B; Shakiba Y; Kiani A; Jamshidi AR; Boroushaki MT
    Int Immunopharmacol; 2013 Nov; 17(3):763-7. PubMed ID: 24055018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinical Use of Curcumin for the Treatment of Recurrent Aphthous Stomatitis: A Systematic Review of Clinical Trials.
    Gharibpour F; Fakheran O; Parvaneh A; Shirban F; Bagherniya M; Sathyapalan T; Sahebkar A
    Adv Exp Med Biol; 2021; 1291():229-238. PubMed ID: 34331693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review of the Clinical Use of Curcumin for the Treatment of Osteoarthritis.
    Shokri-Mashhadi N; Bagherniya M; Askari G; Sathyapalan T; Sahebkar A
    Adv Exp Med Biol; 2021; 1291():265-282. PubMed ID: 34331696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of moxibustion on pain behaviors in patients with rheumatoid arthritis: A meta-analysis.
    Shen B; Sun Q; Chen H; Li Y; Du X; Li H; Xu GY
    Medicine (Baltimore); 2019 Jul; 98(30):e16413. PubMed ID: 31348241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
    Chandrashekara S; Priyanka BU
    Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Paulus HE; Ramos B; Wong WK; Ahmed A; Bulpitt K; Park G; Sterz M; Clements P
    J Rheumatol; 1999 Nov; 26(11):2324-31. PubMed ID: 10555885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.